Timeline.
The source-linked record.
Browse the company, project, intellectual-property, assurance and commentary records currently used on this website.
Every entry links to its underlying source. Publication confirms the record shown; it does not by itself prove adoption, endorsement or impact.
Browse the record.
Use the entity, year and record-type controls together. The list updates immediately and keeps the source attached to every entry.
Showing 18 of 18 source-linked records.
NEUVIOR Pharmaceuticals Ltd incorporated in Scotland.
NEUVIORCompanies House Project record
The Innovate UK PHARMORIS project period began; the public record is now closed.
PHARMORISUKRI Intellectual property
PHARMORIS UK trade-mark application published in the Trade Mark Journal.
PHARMORISUK IPO Project record
The Innovate UK VIONIX ZERO feasibility-project period began; the public record is now closed.
VIONIX ZEROUKRI Commentary
BusinessCloud published Varun’s commentary on neurodivergent founders and complex systems.
Varun SharmaBusinessCloud Assurance record
2025–26 NHS DSP Toolkit submission published as “Standards met”.
NEUVIORDSP Toolkit Project coverage
BDC reported completion of Innovate UK-funded feasibility work in York.
VIONIX ZEROBDC Commentary
Startups Magazine published Varun’s founder story about lessons from family business.
Varun SharmaStartups Magazine Funding coverage
Scottish business media reported NEUVIOR’s selection for SMART:SCOTLAND support. This index does not derive totals beyond the published report.
PHARMORISTheBusinessDesk Commentary
Manufacturing Chemist published Varun’s medicines-access commentary.
Varun SharmaManufacturing Chemist Commentary
PharmaTimes published “How we roll”; the earlier publisher byline is mapped on the biography page.
Varun SharmaPharmaTimes Commentary
Pharmaceutical Technology published Varun’s five-gate implementation commentary on the India–UK trade deal.
Varun SharmaPharmaceutical Technology Published letter
The Financial Times published Varun’s letter on turning invention into adoption; the earlier publisher byline is mapped on the biography page.
Varun SharmaFinancial Times Commentary
ETPharma published Varun’s commentary on sustaining pharmaceutical quality after inspection.
Varun SharmaETPharma Commentary
TechRadar Pro published Varun’s five tests for genuine enterprise AI control.
Varun SharmaTechRadar Pro Commentary
Pharmaphorum published Varun’s analysis of the implementation gap between medicines approval and access.
Varun SharmaPharmaphorum Podcast appearance
Varun joined AI Ethics Now to discuss human accountability, false confidence and AI-assisted decisions.
Varun SharmaAI Ethics Now / University of Warwick IATL Commentary
Express Pharma published Varun’s article on five proofs for India’s pharmaceutical future.
Varun SharmaExpress Pharma